Surveillance after curative resection for colorectal cancer;Oppfølging etter kurativ kirurgi for kolorektal kreft

Tidsskrift for den Norske Laegeforening

Volumn 127, Issue 22, 2007, Pages 2959-2962

  Kørner, Hartwig ^a,b   Søreide, Kjetil ^c   Stokkeland, Pål Johan ^c   Træland, Jan Hallvard ^c   Søreide, Jon Arne ^b,c  

^a Kirurgisk Avdeling   (Norway)

^b RAG Mining Solutions GmbH   (Germany)

^c Avdeling for Patologi ^*

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

BLOOD; COLONOSCOPY; COLORECTAL TUMOR; FOLLOW UP; HUMAN; MORTALITY; NORWAY; REVIEW;

CARCINOEMBRYONIC ANTIGEN; COLONOSCOPY; COLORECTAL NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; NORWAY; TUMOR MARKERS, BIOLOGICAL;

EID: 37549060349     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Weitz J, Koch M, Debus J et al. Colorectal cancer. Lancet 2005; 365: 153-65.
2. Kreftregisteret. Cancer in Norway 2005. Oslo: Kreftregisteret, 2006.
3. Kørner H, Søreide K, Stokkeland PJ et al. Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance. J Gastrointest Surg 2005; 9: 320-8.
4. Biggs CG, Ballantyne GH. Sensitivity versus cost effectiveness in postoperative follow-up for colorectal cancer. Curr Opin Gen Surg 1994: 94-102.
5. Kraemer M, Wiratkapun S, Seow-Choen F et al. Stratifying risk factors for follow-up: a comparison of recurrent and nonrecurrent colorectal cancer. Dis Colon Rectum 2001; 44: 815-21.
6. Norsk Gastrointestinal Cancergruppe. Kontrollopplegg ved kolorektalcancer. 2004 www.ngicg.no/gronnbok/k11.htm (06.3.2007).
7. Jeffery M, Hickey B, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2007: CD002200.
8. Renehan AG, Egger M, Saunders MP et al. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 2002; 324: 813.
9. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2002: CD002200.
10. Rosen M, Chan L, Beart RW et al. Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum 1998; 41: 1116-26.
11. Kievit J. Colorectal cancer follow-up: a reassessment of empirical evidence on effectiveness. Eur J Surg Oncol 2000; 26: 322-8.
12. McArdle C. ABC of colorectal cancer: effectiveness of follow up. BMJ 2000; 321: 1332-5.
13. Kjeldsen BJ, Kronborg O, Fenger C et al. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg 1997; 84: 666-9.
14. Makela JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 1995; 130: 1062-7.
15. Ohlsson B, Breland U, Ekberg H et al. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum 1995; 38: 619-26.
16. Pietra N, Sarli L, Costi R et al. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon Rectum 1998; 41: 1127-33.
17. Rodriguez-Moranta F, Salo J, Arcusa A et al. Post-operative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol 2006; 24: 386-93.
18. Schoemaker D, Black R, Giles L et al. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 1998; 114: 7-14.
19. Secco GB, Fardelli R, Gianquinto D et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 2002; 28: 418-23.
20. Wattchow DA, Weller DP, Esterman A et al. General practice vs. surgical-based follow-up for patients with colon cancer: randomised controlled trial. Br J Cancer 2006; 94: 1116-21.
21. FACS Follow-up After Colorectal Surgery. www.facs.soton.ac.uk/ (7.3.2007).
22. COLOFOL study. www.colofol.com/Index.htm (7.3.2007).
23. Schaefer O, Langer M. Detection of recurrent rectal cancer with CT, MRI and PET/CT. Eur Radiol 2007; 17: 2044-54.
24. Wanebo JH, Stearns M, Schwartz MK. Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer. Ann Surg 1978; 188: 481-93.
25. Northover J. The use of prognostic markers in surgery for colorectal cancer. Eur J Cancer 1995; 31: 1207-9.
26. Kørner H, Søreide K, Stokkeland PJ et al. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis. Ann Surg Oncol 2007; 14: 417-23.
27. Audisio RA, Robertson C. Colorectal cancer follow-up: perspectives for future studies. Eur J Surg Oncol 2000; 26: 329-37.
28. Audisio RA, Setti-Carraro P, Segala M et al. Follow-up in colorectal cancer patients: a cost-benefit analysis. Ann Surg Oncol 1996; 3: 349-57.
29. Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med 2005; 352: 476-87.
30. Søreide K, Janssen EA, Søiland H et al. Microsatellite instability in colorectal cancer. Br J Surg 2006; 93: 395-406.